Navigation Links
TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
Date:12/10/2007

Data from Pivotal Study Show Bendamustine Produced a Significant Increase

in Overall Response Rate and Progression Free Survival

FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a pivotal study of treatment-naive patients with chronic lymphocytic leukemia (CLL), those who received TREANDA (bendamustine HCl) had better clinical outcomes compared to patients treated with chlorambucil, an FDA-approved therapy for patients with CLL. TREANDA(R) is a novel investigational chemotherapy that is currently under priority review by the U.S. Food and Drug Administration (FDA). CLL is a slowly progressing blood and bone marrow disease with an estimated 15,000 new cases diagnosed every year in the United States, according to the National Cancer Institute. The final data from this large, international, multi-center study were presented at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, GA [Poster # 233-II; Abstract #2043].

"In this study, bendamustine was more effective than chlorambucil in achieving remissions in treatment-naive patients with CLL," said Dr. Wolfgang Knauf, Onkologische Gemeinschaftspraxis, Frankfurt, Germany and lead investigator of this study. "On the basis of these positive results, bendamustine could be an important first-line chemotherapy option for patients with CLL."

Bendamustine demonstrated significantly better outcomes in both of the primary endpoints: overall response rate and progression-free survival (PFS). Overall response rate was significantly higher with bendamustine than with chlorambucil (68% vs. 39%) (p<0.0001) with a strong complete response rate of 30% compared to 2%, a nodular partial response of 10% compared to 3%, and a partial response of 28% compared to 34%, respectively. Bendamustine significantly improved PFS compared to chlorambucil (median PFS 21.7 months vs. 9.3 months (p<.0001)). The median duration of response
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
2. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
3. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
7. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
8. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Surgeons at The Children,s Hospital of ... report the first successful use of a SynCardia temporary ... with failing Fontan circulation to bridge him to a ... old, the patient received a Fontan circulation procedure to ... "The Fontan operation is the final planned palliative operation ...
(Date:9/16/2014)... 2014   Evana Automation Specialists , a leading ... test systems, recently received a contract to provide a ... The Evana solution will help error-proof the process of ... as reduce labor. A catheter adapter, ... assembly cell. The robot will pick the adapter, connector ...
(Date:9/16/2014)... , Sept. 16, 2014   HemCon Medical ... of TriStar Wellness Solutions(R), Inc. (OTCQB: ... advanced medical products, announced today that the revenue ... by 39 percent, and microdispersed oxidized cellulose raw ... 2014.  Overall, TWSI expects third quarter revenues to ...
Breaking Medicine Technology:13-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 2HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 4
... Generex Biotechnology Corporation (OTCBB: GNBT) ( www.generex.com ) is ... of developments that have been achieved since the appointment ... on September 29, 2010. "Since my appointment ... have made it a priority to proactively communicate significant ...
... 2, 2011 Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... 2011 on Tuesday, August 16 , 2011 at approximately 8:00 ... 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s Chairman ... be available live via webcast to interested parties on the ...
Cached Medicine Technology:Generex Provides Corporate Update 2Generex Provides Corporate Update 3Generex Provides Corporate Update 4Generex Provides Corporate Update 5Generex Provides Corporate Update 6Generex Provides Corporate Update 7Generex Provides Corporate Update 8
(Date:9/16/2014)... 2014 A new study found that fractional ... of true coronary bifurcation lesions yields similar outcomes ... clinical trial is the first study to compare ... reported today at the 26th annual Transcatheter Cardiovascular ... Research Foundation (CRF), TCT is the world,s premier ...
(Date:9/16/2014)... be able to predict when and how much various ... in part to new findings that researchers at Fox ... Radiation Oncology,s 56th Annual Meeting on Tuesday, September 16. ... surveys completed by men diagnosed with prostate cancer, Fox ... changed following each type of treatment, and by how ...
(Date:9/16/2014)... September 16, 2014 Seven heroes who ... world will be honored in New York City on ... ), the only global recognition and funding program that ... by the media as the “Nobel Prize for Child ... created life-changing programs that benefit children in countries around ...
(Date:9/16/2014)... September 16, 2014 AcousticSheep LLC, makers ... to launch RunPhones® Wireless, their latest version of RunPhones® ... sport-style headband for active people seeking a safe, comfortable ... on the market and will be available October ... Wireless has all of the same great features as ...
(Date:9/16/2014)... (HealthDay News) -- Including women older than 70 in ... sharp reduction in advanced forms of the disease, a ... screening programs could result in older women being overdiagnosed ... decision to screen older women for breast cancer should ... "Instead of using mass screening, the decision to participate ...
Breaking Medicine News(10 mins):Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 3Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2
... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
... , WALTHAM, Mass., June 19 I-Therapeutix announced today that ... The round was led by Polaris Venture Partners in ... and SV Life Sciences. , , The ... the United States and to develop sustained drug delivery products ...
... to sign a bill giving the Food and Drug ... study from Harvard School of Public Health (HSPH) researchers ... and the design of their cigarettes over time, even ... The result, say the researchers, is that consumers who ...
... tests find cannabis even more toxic than tobacco, , FRIDAY, ... plant from which marijuana is derived, contains compounds that can ... tobacco smoke, says a new study from the United Kingdom. ... of Leicester and colleagues found certain carcinogens in cannabis smoke ...
... asks for less institutional, more personal care , FRIDAY, ... where residents are free to make choices regarding their ... home, according to a guidance issued Friday by the ... The directives in the CMS guidance aim to "transform ...
... own self be true" may take on a new ... behavior. Plants engage in self-recognition and can communicate ... nearby, says professor Richard Karban of the Department of ... in the current edition of Ecology Letters . ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:I-Therapeutix, Inc. Closes $15 Million Financing 2Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2Health News:Make Nursing Homes More Like Home: Medicare 2Health News:Plant communication: Sagebrush engage in self-recognition and warn of danger 2
... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...
50L...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: